Literature DB >> 16125267

Preparation and characterization of biodegradable nanoparticles based on poly(gamma-glutamic acid) with l-phenylalanine as a protein carrier.

Takami Akagi1, Tatsuo Kaneko, Toshiyuki Kida, Mitsuru Akashi.   

Abstract

The objective of the present study was to prepare nanoparticles composed of poly(gamma-glutamic acid) (gamma-PGA) and l-phenylalanine ethylester (l-PAE) in order to evaluate the possibility of using these nanoparticles as protein carriers. Novel amphiphilic graft copolymers composed of gamma-PGA as the hydrophilic backbone and l-PAE as the hydrophobic segment were successfully synthesized by grafting l-PAE to gamma-PGA using water-soluble carbodiimide (WSC). Due to their amphiphilic properties, the gamma-PGA-graft-l-PAE copolymers were able to form nanoparticles. The size of the gamma-PGA nanoparticles was measured by photon correlation spectroscopy (PCS) and showed a monodispersed size distribution with a mean diameter ranging from 150 to 200 nm. The solvents selected to prepare the gamma-PGA nanoparticles by a precipitation and dialysis method affected the particle size distribution. To evaluate the feasibility of vehicles for these proteins, we prepared protein-loaded gamma-PGA nanoparticles by surface immobilization and encapsulation methods. Ovalbumin (OVA) was used as a model protein and was immobilized onto the gamma-PGA nanoparticles or encapsulated into the inner core of these nanoparticles. Moreover, these OVA-encapsulated gamma-PGA nanoparticles could be preserved by freeze-drying process. The results of cytotoxicity tests showed that the gamma-PGA and gamma-PGA nanoparticles did not cause any relevant cell damage. It is expected that biodegradable gamma-PGA nanoparticles can immobilize proteins, peptides, plasmid DNA and drugs onto their surfaces and/or into the nanoparticles. These nanoparticles are potentially useful in pharmaceutical and biomedical applications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16125267     DOI: 10.1016/j.jconrel.2005.08.003

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  25 in total

1.  Composition and characterization of in situ usable light cured dental drug delivery hydrogel system.

Authors:  József Bakó; Miklós Vecsernyés; Zoltán Ujhelyi; Ildikó Bácskay Kovácsné; István Borbíró; Tamás Bíró; János Borbély; Csaba Hegedűs
Journal:  J Mater Sci Mater Med       Date:  2012-12-11       Impact factor: 3.896

Review 2.  Biomaterials for nanoparticle vaccine delivery systems.

Authors:  Preety Sahdev; Lukasz J Ochyl; James J Moon
Journal:  Pharm Res       Date:  2014-05-22       Impact factor: 4.200

3.  Uptake of biodegradable poly(γ-glutamic acid) nanoparticles and antigen presentation by dendritic cells in vivo.

Authors:  Tomofumi Uto; Masaaki Toyama; Yosuke Nishi; Takami Akagi; Fumiaki Shima; Mitsuru Akashi; Masanori Baba
Journal:  Results Immunol       Date:  2012-12-03

4.  Modulation of gene expression related to Toll-like receptor signaling in dendritic cells by poly(gamma-glutamic acid) nanoparticles.

Authors:  Takayuki Hamasaki; Tomofumi Uto; Takami Akagi; Mitsuru Akashi; Masanori Baba
Journal:  Clin Vaccine Immunol       Date:  2010-03-10

5.  Poly-γ-glutamic acid nanoparticles and aluminum adjuvant used as an adjuvant with a single dose of Japanese encephalitis virus-like particles provide effective protection from Japanese encephalitis virus.

Authors:  Shigefumi Okamoto; Hironori Yoshii; Masaaki Matsuura; Asato Kojima; Toyokazu Ishikawa; Takami Akagi; Mitsuru Akashi; Michiaki Takahashi; Koichi Yamanishi; Yasuko Mori
Journal:  Clin Vaccine Immunol       Date:  2011-11-16

6.  Intranasal immunization with a formalin-inactivated human influenza A virus whole-virion vaccine alone and intranasal immunization with a split-virion vaccine with mucosal adjuvants show similar levels of cross-protection.

Authors:  Shigefumi Okamoto; Sumiko Matsuoka; Nobuyuki Takenaka; Ahmad M Haredy; Takeshi Tanimoto; Yasuyuki Gomi; Toyokazu Ishikawa; Takami Akagi; Mitsuru Akashi; Yoshinobu Okuno; Yasuko Mori; Koichi Yamanishi
Journal:  Clin Vaccine Immunol       Date:  2012-05-02

7.  Induction of potent adaptive immunity by the novel polyion complex nanoparticles.

Authors:  Tomofumi Uto; Takami Akagi; Mitsuru Akashi; Masanori Baba
Journal:  Clin Vaccine Immunol       Date:  2015-03-25

8.  Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes.

Authors:  Rebecca Voltan; Arianna Castaldello; Egidio Brocca-Cofano; Giuseppe Altavilla; Antonella Caputo; Michele Laus; Katia Sparnacci; Barbara Ensoli; Silvia Spaccasassi; Marco Ballestri; Luisa Tondelli
Journal:  Pharm Res       Date:  2007-05-03       Impact factor: 4.200

Review 9.  Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases.

Authors:  Akhilesh Kumar Shakya; Kutty Selva Nandakumar
Journal:  J R Soc Interface       Date:  2013-02       Impact factor: 4.118

10.  Induction of potent CD8+ T-cell responses by novel biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120.

Authors:  Xin Wang; Tomofumi Uto; Takami Akagi; Mitsuru Akashi; Masanori Baba
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.